Correction of high astigmatism in cataract patients with a toric IOL with a Z-haptic

Article

A retrospective study of cataract patients who underwent phacoemulsification with implantation of the Toric Microsil 6116 TU IOL is described.

Nowadays, eliminating visually significant preexisting astigmatism at the time of cataract surgery has become a key factor for a successful outcome. The advent of toric intraocular lenses (IOLs) has been a major breakthrough in refractive correction because it offers the possibility of correcting pre-existing corneal astigmatism and spherical refractive errors during cataract surgery with only slight adjustments in technique. It has been estimated that approximately 22% of cataract patients have corneal astigmatism of 1.5 D or higher and would benefit from toric IOL implantation.1 Many manufacturers now supply toric IOLs.2 However, options for treating patients with very high spherocylindrical errors are still limited.

Our study

Patients were observed 1 day, 1 week, 1, 3 and ≥6 months (range 6 to 18 months) after surgery. Monocular distance uncorrected visual acuity (UCVA), refraction, keratometry and IOL alignment were recorded at each follow-up visit.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.